NKG2A-HLA-E axis contributes to an immunosuppressive checkpoint network in hepatocellular carcinoma
Journal for ImmunoTherapy of Cancer · 2026
DOI: 10.1136/jitc-2026-015639 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal for ImmunoTherapy of Cancer, 2026. Verfasst von Yan Li und 17 weiteren Autor:innen. Beteiligte Einrichtung: Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, NK Cell Lectin-Like Receptor Subfamily C, Liver Neoplasms, Histocompatibility Antigens Class I. Die Arbeit nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Medical Research Fund, Shenzhen Science and Technology Program.
Abstract (Originalsprache)
Background
The immunosuppressive tumor microenvironment in hepatocellular carcinoma (HCC) limits the efficacy of current immunotherapies. The interplay between the emerging inhibitory receptor NKG2A and its activating counterpart NKG2C, both binding HLA-E, and its interaction with the PD-1-PD-L1 pathway in cancer remains unclear. This study aims to delineate the functional network formed by these pathways in shaping the immunosuppressive landscape of HCC.
Methods
We analyzed public databases and performed immunohistochemistry on HCC tissues to assess HLA-E expression and prognostic relevance. Tumor-infiltrating lymphocytes from patient samples were examined by flow cytometry to evaluate the functional impact of NKG2A, NKG2C, and PD-1 expression on T and NK cells. Single-cell RNA and T cell receptor (TCR) sequencing were employed to characterize immune subset heterogeneity. Functional assays and mouse models were used to evaluate the effects of NKG2A and PD-1 blockade.
Results
In the absence of CD8 + T cell infiltration, elevated HLA-E expression in HCC tissue correlated with poorer overall survival in non-immunotherapy-treated patients. Conversely, in the presence of CD8 + T cells, high HLA-E expression was linked to an inflammatory tumor microenvironment characterized by IFN-γ-producing T cells, and increased major histocompatibility complex I, which was associated with improved patient response to immunotherapy. Tumor-infiltrating CD8 + T and NK cells from HCC patients upregulated NKG2A, conferring tissue-resident memory and tumor-reactive characteristics while simultaneously impairing cytotoxic function. Single-cell RNA and TCR sequencing revealed differential expression patterns of NKG2A, NKG2C, and PD-1 in different T and NK cell subsets, with NKG2A + PD-1 + T cells relevant to antigen-specific clonal expansion. Mechanistically, the inhibitory effect mediated by the NKG2A-HLA-E axis contributed more prominently than the stimulatory role of the NKG2C-HLA-E axis in suppressing antitumor immunity. Furthermore, the NKG2A-HLA-E axis acted cooperatively with the PD-1-PD-L1 axis to promote CD8 + T cell dysfunction. Combined blockade of NKG2A and PD-1 enhanced the cytotoxic activity of tumor-infiltrating CD8 + T and NK cells, resulting in potent tumor eradication in vitro and in vivo, outperforming single-agent treatments.
Conclusions
Our findings identify the NKG2A-HLA-E axis as an important immunoregulatory pathway associated with immune suppression in HCC and provide a rationale for further evaluation of combined NKG2A and PD-1 blockade strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Scientific Research Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
- Department of General Surgery, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
- Guangdong Provincial Key Laboratory of Digestive Cancer Research, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
- Digestive Diseases Center, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
- Department of Dermatology, The Seventh Affiliated Hospital, Sun Yat-sen University, Shenzhen, Guangdong, China.
- Department of Dermatology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, China.
Förderung
- National Natural Science Foundation of China
- Shenzhen Medical Research Fund
- Shenzhen Science and Technology Program
- Guangdong Basic and Applied Basic Research Foundation
- 100 Top Talents Program of Sun Yat-sen University and Research Start-up Fund of the Seventh Affiliated Hospital, Sun Yat-sen University
Zitieren
APA
Li, Y., Zhuang, X., Tang, Y., Feng, W., Huang, Y., Li, Z., Lin, Y., Tang, D., Deng, G., Peng, S., Qin, W., Chen, Z., Wu, X., Song, Z., Boor, P. P. C., Buschow, S. I., Sprengers, D., & Zhou, G. (2026). NKG2A-HLA-E axis contributes to an immunosuppressive checkpoint network in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. https://doi.org/10.1136/jitc-2026-015639
Vancouver
Li Y, Zhuang X, Tang Y, Feng W, Huang Y, Li Z, et al. NKG2A-HLA-E axis contributes to an immunosuppressive checkpoint network in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 2026. doi:10.1136/jitc-2026-015639
BibTeX
@article{Li2026,
author = {Li, Yan and Zhuang, Xiaomei and Tang, Yisen and Feng, Wanhua and Huang, Yingzi and Li, Zhu and Lin, Yuanyu and Tang, Di and Deng, Gang and Peng, Songlin and Qin, Wei and Chen, Zubing and Wu, Xiaoying and Song, Ze and Boor, Patrick P C and Buschow, Sonja I and Sprengers, Dave and Zhou, Guoying},
title = {NKG2A-HLA-E axis contributes to an immunosuppressive checkpoint network in hepatocellular carcinoma},
journal = {Journal for ImmunoTherapy of Cancer},
year = {2026},
doi = {10.1136/jitc-2026-015639}
}
EUVIMED